Registration number:
Glow Medical Aesthetics Ltd
trading as
for the Year Ended 31 August 2018
Glow Medical Aesthetics Ltd
trading as Medicetics
Contents
Company Information |
|
Accountants' Report |
|
Statement of Comprehensive Income |
|
Balance Sheet |
|
Statement of Changes in Equity |
|
Notes to the Financial Statements |
Glow Medical Aesthetics Ltd
trading as Medicetics
Company Information
Directors |
Dr Geoffrey Mullan Dr Vicky Dondos |
Company secretary |
Dr Vicky Dondos |
Registered office |
|
Accountants |
|
Page 1 |
Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Glow Medical Aesthetics Ltd
trading as Medicetics
for the Year Ended 31 August 2018
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Glow Medical Aesthetics Ltd for the year ended 31 August 2018 as set out on pages 3 to 12 from the company's accounting records and from information and explanations you have given us.
As a licenced accountant of The Association of Accounting Technicians (AAT), we are subject to its ethical and other professional requirements which are available at www.aat.org.uk/about-aat/professional-standards.
This report is made solely to the Board of Directors of Glow Medical Aesthetics Ltd, as a body, in accordance with the terms of our engagement letter dated 8 July 2015. Our work has been undertaken solely to prepare for your approval the accounts of Glow Medical Aesthetics Ltd and state those matters that we have agreed to state to the Board of Directors of Glow Medical Aesthetics Ltd, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Glow Medical Aesthetics Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Glow Medical Aesthetics Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Glow Medical Aesthetics Ltd. You consider that Glow Medical Aesthetics Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Glow Medical Aesthetics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
......................................
Steven Anderson FMAAT & AAT Licenced Accountant
North Lee Lane
Terrick
Buckinghamshire
HP22 5YB
Page 2 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Statement of Comprehensive Income for the Year Ended 31 August 2018
Note |
2018 |
2017 |
|
Profit for the year |
|
|
|
Total comprehensive income for the year |
|
|
Page 3 |
Glow Medical Aesthetics Ltd
trading as Medicetics
(Registration number: 05908321)
Balance Sheet as at 31 August 2018
Note |
2018 |
2017 |
|
Fixed assets |
|||
Tangible assets |
|
|
|
Current assets |
|||
Stocks |
|
|
|
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current liabilities |
( |
( |
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
- |
( |
|
Provisions for liabilities |
|
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Profit and loss account |
|
|
|
Total equity |
|
|
For the financial year ending 31 August 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Page 4 |
Glow Medical Aesthetics Ltd
trading as Medicetics
(Registration number: 05908321)
Balance Sheet as at 31 August 2018
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
Approved and authorised by the
.........................................
Dr Geoffrey Mullan
Director
.........................................
Dr Vicky Dondos
Company secretary and director
Page 5 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Statement of Changes in Equity for the Year Ended 31 August 2018
Share capital |
Profit and loss account |
Total |
|
At 1 September 2017 |
|
|
|
Profit for the year |
- |
|
|
Total comprehensive income |
- |
|
|
Dividends |
- |
( |
( |
At 31 August 2018 |
|
|
|
Share capital |
Profit and loss account |
Total |
|
At 1 September 2016 |
|
|
|
Profit for the year |
- |
|
|
Total comprehensive income |
- |
|
|
Dividends |
- |
( |
( |
At 31 August 2017 |
|
|
|
Page 6 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Notes to the Financial Statements for the Year Ended 31 August 2018
General information |
The company is a private company limited by share capital incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
The financial statements have been prepared on a going concern basis.
Tangible assets
Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Short Leasehold |
5% on Cost |
Plant & Machinery |
10% on reducing balance |
Fixtures & Fittings |
10% on reducing balance |
Computer Equipment |
25% on Cost |
Page 7 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Notes to the Financial Statements for the Year Ended 31 August 2018
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Page 8 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Notes to the Financial Statements for the Year Ended 31 August 2018
Provisions
Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
Leases
Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.
Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.
Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Defined contribution pension obligation
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Page 9 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Notes to the Financial Statements for the Year Ended 31 August 2018
Tangible assets |
Land and buildings |
Furniture, fittings and equipment |
Other property, plant and equipment |
Total |
|
Cost or valuation |
||||
At 1 September 2017 |
|
|
|
|
Additions |
- |
|
- |
|
At 31 August 2018 |
|
|
|
|
Depreciation |
||||
At 1 September 2017 |
|
|
|
|
Charge for the year |
|
|
|
|
At 31 August 2018 |
|
|
|
|
Carrying amount |
||||
At 31 August 2018 |
|
|
|
|
At 31 August 2017 |
|
|
|
|
Included within the net book value of land and buildings above is £30,031 (2017 - £33,031) in respect of freehold land and buildings.
Stocks |
2018 |
2017 |
|
Other inventories |
|
|
Debtors |
2018 |
2017 |
|
Other debtors |
|
|
Total current trade and other debtors |
|
|
Page 10 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Notes to the Financial Statements for the Year Ended 31 August 2018
Creditors |
Note |
2018 |
2017 |
|
Due within one year |
|||
Bank loans and overdrafts |
|
|
|
Trade creditors |
|
|
|
Taxation and social security |
|
|
|
Other creditors |
|
|
|
|
|
||
Due after one year |
|||
Loans and borrowings |
- |
|
Loans and borrowings |
2018 |
2017 |
|
Non-current loans and borrowings |
||
Bank borrowings |
- |
|
2018 |
2017 |
|
Current loans and borrowings |
||
Bank borrowings |
|
|
Finance lease liabilities |
- |
|
|
|
Bank borrowings
*** The Equipment of the company has been used as security by the bank.*** |
Page 11 |
Glow Medical Aesthetics Ltd
trading as Medicetics
Notes to the Financial Statements for the Year Ended 31 August 2018
Dividends |
2018 |
2017 |
|
£ |
£ |
|
Interim dividend of £
|
450,053 |
374,000 |
The directors are proposing a final dividend of £Nil (2017 - £Nil) per share totalling £Nil (2017 - £Nil). This dividend has not been accrued in the Balance Sheet.
Page 12 |